Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Panagiota Papanagnou"'
Publikováno v:
Biomolecules, Vol 6, Iss 4, p 44 (2016)
MicroRNAs (miRNAs) are small, non-coding RNA species that are highly evolutionarily conserved, from higher invertebrates to man. Up to 1000 miRNAs have been identified in human cells thus far, where they are key regulators of the expression of numero
Externí odkaz:
https://doaj.org/article/ba09680e5afb42719caf8ec555f96841
Publikováno v:
Pharmaceuticals, Vol 9, Iss 2, p 24 (2016)
The development of efficacious antitumor compounds with minimal toxicity is a hot research topic. Numerous cancer cell targeted agents are evaluated daily in laboratories for their antitumorigenicity at the pre-clinical level, but the process of thei
Externí odkaz:
https://doaj.org/article/c64a74b0282a44a1819b822e4b3dc23a
Autor:
Panagiota Papanagnou
MicroRNAs (miRNAs) are small, non-coding RNA species that are highly evolutionarily conserved, from higher invertebrates to man. Up to 1000 miRNAs have been identified in human cells thus far, where they are key regulators of the expression of numero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6599e60ce05888a072081188d1552c3
https://doi.org/10.9734/bpi/ctmamr/v12/6519d
https://doi.org/10.9734/bpi/ctmamr/v12/6519d
Publikováno v:
OncoTargets and therapy
Pleiotropy in biological systems and their targeting allows many pharmaceuticals to be used for multiple therapeutic purposes. Fully exploiting the therapeutic properties of drugs that are already marketed would be highly advantageous. This is especi
Autor:
Georgios Papadopoulos, Anastasios Pappas, Panagiota Papanagnou, Theodora Stivarou, Ioannis Papageorgiou
Publikováno v:
OncoTargets and therapy
The design of novel pharmacologic agents as well as their approval for sale in markets all over the world is a tedious and pricey process. Inevitably, oncologic patients commonly experience unwanted effects of new anticancer drugs, while the acquisit
Publikováno v:
Therapeutics and Clinical Risk Management
Experimental data indicate that several pharmacological agents that have long been used for the management of various diseases unrelated to cancer exhibit profound in vitro and in vivo anticancer activity. This is of major clinical importance, since
Autor:
Paul A. Townsend, Daniel Schramek, Josef M. Penninger, Athanassios Kotsinas, Jiri Bartek, Panagiota Papanagnou, Vassilis G. Gorgoulis, Panagiotis Galanos
Publikováno v:
Cell Cycle. 13:1227-1236
Sensing, integrating, and processing of stressogenic signals must be followed by accurate differential response(s) for a cell to survive and avoid malignant transformation. The DNA damage response (DDR) pathway is vital in this process, as it deals w
Publikováno v:
Biomolecules
Biomolecules, Vol 6, Iss 4, p 44 (2016)
Biomolecules, Vol 6, Iss 4, p 44 (2016)
MicroRNAs (miRNAs) are small, non-coding RNA species that are highly evolutionarily conserved, from higher invertebrates to man. Up to 1000 miRNAs have been identified in human cells thus far, where they are key regulators of the expression of numero
Autor:
Michael Zachariadis, Konstantinos Evangelou, Nikolaos G. Kastrinakis, Panagiota Papanagnou, Vassilis G. Gorgoulis
Publikováno v:
Key Topics in Surgical Research and Methodology ISBN: 9783540719144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e036949a2c629358fe5a053b66403d8
https://doi.org/10.1007/978-3-540-71915-1_74
https://doi.org/10.1007/978-3-540-71915-1_74